Bromelain-loaded nanocomposites decrease inflammatory and cytotoxicity effects of gliadin on Caco-2 cells and peripheral blood mononuclear cells of celiac patients

Enzyme therapy can be an appropriate treatment option for celiac disease (CeD). Here, we developed Bromelain-Loaded Nanocomposites (BLNCs) to improve the stability and retention of bromelain enzyme activity. After the characterization of BLNCs, the cytotoxicity of BLNCs was determined on the Caco-2...

Descripción completa

Detalles Bibliográficos
Autores principales: Mousavi Maleki, Masoumeh Sadat, Ebrahimi kiasari, Ramin, Seyed Mousavi, Seyed Javad, Hashemi‐Moghaddam, Hamid, Shabani, Ali Akbar, Madanchi, Hamid, Sardari, Soroush
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692183/
https://www.ncbi.nlm.nih.gov/pubmed/38040898
http://dx.doi.org/10.1038/s41598-023-48460-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692183/
https://www.ncbi.nlm.nih.gov/pubmed/38040898
http://dx.doi.org/10.1038/s41598-023-48460-3

Ejemplares similares